Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:380-388
Published online before print December 13, 2007, doi: 10.1161/CIRCRESAHA.107.161059
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/3/380    most recent
CIRCRESAHA.107.161059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Bizri, N.
Right arrow Articles by Rabinovitch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Bizri, N.
Right arrow Articles by Rabinovitch, M.
Related Collections
Right arrow Remodeling
Right arrow Apoptosis
Right arrow Genetically altered mice
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation
Right arrow Pulmonary circulation and disease
(Circulation Research. 2008;102:380.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Smooth Muscle Protein 22{alpha}–Mediated Patchy Deletion of Bmpr1a Impairs Cardiac Contractility but Protects Against Pulmonary Vascular Remodeling

Nesrine El-Bizri, Lingli Wang, Sandra L. Merklinger, Christophe Guignabert, Tushar Desai, Takashi Urashima, Ahmad Y. Sheikh, Russell H. Knutsen, Robert P. Mecham, Yuji Mishina, Marlene Rabinovitch

From the Cardiopulmonary Research Program (N.E.-B., L.W., S.L.M., C.G., M.R.), Vera Moulton Wall Center for Pulmonary Vascular Disease; Departments of Pediatrics (N.E.-B., L.W., S.L.M., C.G., T.U. M.R.), Biochemistry (T.D.), Pulmonary and Critical Care Medicine (T.D.), and Cardiothoracic Surgery (A.Y.S.), Stanford University School of Medicine, Calif; Department of Cell Biology (R.H.K., R.P.M.), Washington University School of Medicine, St Louis, Mo; and Molecular Developmental Biology Group (Y.M.), Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC.

Correspondence to Marlene Rabinovitch, MD, Stanford University School of Medicine, CCSR-2245B, 269 Campus Dr, Stanford, CA 94305-5162. E-mail marlener{at}stanford.edu

Vascular expression of bone morphogenetic type IA receptor (Bmpr1a) is reduced in lungs of patients with pulmonary arterial hypertension, but the significance of this observation is poorly understood. To elucidate the role of Bmpr1a in the vascular pathology of pulmonary arterial hypertension and associated right ventricular (RV) dysfunction, we deleted Bmpr1a in vascular smooth muscle cells and in cardiac myocytes in mice using the SM22{alpha};TRE-Cre/LoxP;R26R system. The LacZ distribution reflected patchy deletion of Bmpr1a in the lung vessels, aorta, and heart of SM22{alpha};TRE-Cre;R26R;Bmpr1aflox/+ and flox/flox mutants. This reduction in BMPR-IA expression was confirmed by Western immunoblot and immunohistochemistry in the flox/flox group. This did not affect pulmonary vasoreactivity to acute hypoxia (10% O2) or the increase in RV systolic pressure and RV hypertrophy following 3 weeks in chronic hypoxia. However, both SM22{alpha};TRE-Cre;R26R;Bmpr1aflox/+ and flox/flox mutant mice had fewer muscularized distal pulmonary arteries and attenuated loss of peripheral pulmonary arteries compared with age-matched control littermates in hypoxia. When Bmpr1a expression was reduced by short interference RNA in cultured pulmonary arterial smooth muscle cells, serum-induced proliferation was attenuated explaining decreased hypoxia-mediated muscularization of distal vessels. When Bmpr1a was reduced in cultured microvascular pericytes by short interference RNA, resistance to apoptosis was observed and this could account for protection against hypoxia-mediated vessel loss. The similar elevation in RV systolic pressure and RV hypertrophy, despite the attenuated remodeling with chronic hypoxia in the flox/flox mutants versus controls, was not a function of elevated left ventricular end diastolic pressure but was associated with increased periadventitial deposition of elastin and collagen, potentially influencing vascular stiffness.


Key Words: Bmpr1a (Alk3) • pulmonary hypertension • hypoxia • smooth muscle cell • pericyte • transgenic mice




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Guignabert, C. M. Alvira, T.-P. Alastalo, H. Sawada, G. Hansmann, M. Zhao, L. Wang, N. El-Bizri, and M. Rabinovitch
Tie2-mediated loss of peroxisome proliferator-activated receptor-{gamma} in mice causes PDGF receptor-{beta}-dependent pulmonary arterial muscularization
Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1082 - L1090.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Shifren, A. G. Durmowicz, R. H. Knutsen, G. Faury, and R. P. Mecham
Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure
J Appl Physiol, November 1, 2008; 105(5): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. El-Bizri, C. Guignabert, L. Wang, A. Cheng, K. Stankunas, C.-P. Chang, Y. Mishina, and M. Rabinovitch
SM22{alpha}-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis
Development, September 1, 2008; 135(17): 2981 - 2991.
[Abstract] [Full Text] [PDF]